HAART


US Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents Updates


Reasons for Discontinuation of Nevirapine-based HAART Regimens  2/16/07

Role of Traditional Risk Factors vs HAART in the Development of Metabolic Syndrome   - 2/09/07

HAART Outcome Is Not Related to Gender or Route of HIV Transmission   12/08/06

Increased Clinical Events in Patients with Virological Suppression but Persistent CD4 Count below 200 Cells/mm3   9/29/06

Lower HAART Adherence Observed Prior to Viral Load "Blips"   9/29/06

HIV Persists in Aged Memory CD4 Cells during 8 Years of Effective HAART   9/29/06

HAART Followed by Treatment Interruption Provides No Benefit for Patients with Primary HIV Infection - 9/01/06

Cigarette Smoking Is Associated with Faster HIV Disease Progression in Women on HAART - 7/07/06

Anti-HIV Drugs Associated with Elevated Blood Pressure in Patients on HAART- 4/25/06

Absence of Seroreversion in 80 HAART-treated HIV Patients with at Least 5 Years Undetectable HIV Viral Load - 4/18/06

Is Elective Caesarian Section Really Necessary for Prevention of Mother to Child Transmission of HIV in the HAART Era? - 4/07/06

Immune Reconstitution and Predictors of Virologic Failure in Adolescents Initiating HAART - 3/21/06

Understanding and Avoiding the Adverse Events of HAART - 3/14/06

Determinants of Discontinuation of Initial HAART - 3/14/06

Predictors for Changes in CD4 Cell Count 7 Years after Starting HAART - 3/07/06

Health Care Expenditures for HIV Patients in the HAART Era - 2/28/06

Despite Advanced HIV Disease and Poor Virologic Responses, Patients Continuing HAART Can Reduce their Incidence of AIDS Illnesses - 2/24/06

What Is the Optimal TB Therapy Duration for Preventing Relapse in HIV Patients on HAART? - 2/24/06

Discordant Immunologic and Virologic Responses to HAART Are Associated with Increased Risk of Death and Poor Adherence to Therapy - 11/02/05

Clinical Response of AIDS-associated Kaposi's Sarcoma to HAART - 10/26/05

Mortality in Patients with Successful Initial Response to HAART Is Still Higher Than in Non-HIV-infected Individuals   - 10/19/05

Prognostic Factors in HIV-related Diffuse Large-Cell Lymphoma: Before Versus after HAART - 10/24/05 Lack of Employment and the Absence of a Stable Partnership Are Independent Risk Factors for Hospitalization or Death among HIV Patients on HAART - 10/05/05

The Hidden Epidemic: Older Individuals with HIV Infection - 9/07/05

Starting HAART Early Rather Than Later Appears Cost Effective and May Increase Quality Survival Time - 8/26/05

87% of Persons Treated with HAART Will Eventually Achieve a CD4 T cell Count >/= 350 Cells mL that Likely Will Protect against Opportunistic Infections - 7/11/05

Confirmation of Loss of CD4 Cells in Virologically Controlled Patients Treated with Tenofovir/Didanosine-containing HAART - 6/22/05

Stress, Appraisal and Coping among Women with HIV in the pre-HAART and HAART Eras - 6/08/05

Immune Reconstitution Disease Is Associated with Mycobacterial Infections in HIV Patients Receiving Antiretrovirals - 6/08/05

Response to HAART and GB Virus Type C Coinfection in a Cohort of Treatment-naive HIV Patients - 5/23/05

Patients Want Treatment Information Sources That Address Their Individual Needs and Concerns - 4/25/05

Gender Differences in Clinical Progression of HIV Positive Individuals During Long-term HAART - 4/22/05

HAART Improves Prognosis of AIDS-related Lymphoma - 4/22/05

Viral Rebound in Patients on First-line, PI-containing HAART Suggests a Lack of Adherence Rather Than the Selection of Resistant Variants - 4/04/05

A Pilot Study of Lopinavir/ritonavir Maintenance Monotherapy after Successful Viral Suppression with Standard HAART - 3/30/05

Therapeutic Immunization May Curb HIV After HAART Is Stopped - 3/18/05

HAART Reduces Rates of Kaposi's Sarcoma, Non-Hodgkin Lymphoma But Not Other Cancers - 3/18/05

Dyslipidemia Significantly Increases Cardiac Risk in HAART Patients - 3/16/05

European Research Group Recommends Offering Elective Caesarean Section Delivery to All HIV Positive Women, Even in Areas Where HAART Is Available - 2/04/05

Early HAART Does Not Appear to Lower Virological Set Point - 1/31/05

Changing Incidence and Prognostic Factors of Survival in AIDS-related Non-Hodgkin's Lymphoma in the HAART Era - 1/07/05

Interleukin-7 May Flush Out Latent HIV Reservoirs - 1/07/05

Treatment Interruptions Guided by CD4+ Cell Count Do Not Reduce the Efficacy of HAART in HIV Patients with Good Initial HAART Responses - 1/05/05

The Extraordinary Hope of Antiretroviral Therapy in South Africa (Even for Patients with Tuberculosis or Kaposi Sarcoma!) - 1/03/05

Psychiatric Disorders in AIDS Patients Do Not Affect the Initiation  and Duration of Therapy - 11/24/04

HIV Infection May Increase COPD Risk - 10/29/04

HIV Level After 4 Weeks of HAART Predicts Eventual Virologic Outcome 10/27/04

Factors Influencing Increases in CD4 Cell Counts of HIV Positive Persons Receiving Long-Term HAART  - 10/25/04

Rapid HIV Decay in HAART-experienced Children After Starting Mega-HAART - 10/18/04

The HIV Netherlands, Australia, Thailand Research Collaboration (HIV-NAT): Lessons from 7 Years of Clinical Research  - 10/18/04

Adherence to HAART in the Homeless Population in San Francisco: 31% in Study Discontinued Therapy - 10/06/04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 






 

HIV AND AIDS | HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH AND TECHNOLOGY | TESTS
| INTERNET CONFERENCE REPORTS | TELECONFERENCES | LINKS | ABOUT US | CONTACT US